Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
William Gradishar, Northwestern University Identifier:
First received: April 19, 2006
Last updated: November 6, 2013
Last verified: November 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2011
  Primary Completion Date: August 2011 (Final data collection date for primary outcome measure)